• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

    40.75 +1.90 (+4.89%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about GeneDx Holdings Corp. - Class A Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    GENEDX HOLDINGS CORP. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    GeneDx Holdings Corp. (WGS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
    From Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
    From GeneDx
    Via Business Wire
    News headline image
    Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Participate in Upcoming Investor Conferences
    From GeneDx
    Via Business Wire
    News headline image
    INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
    From GeneDx
    Via Business Wire
    News headline image
    TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
    From GeneDx
    Via Business Wire
    News headline image
    Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
    From GeneDx
    Via Business Wire
    News headline image
    JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Participate in Upcoming Investor Conferences
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
    From GeneDx
    Via Business Wire
    News headline image
    Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
    From GeneDx
    Via Business Wire
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.